Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandra Trejo-Martin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Regulatory Toxicology and Pharmacology : RTP|February 1, 2026
Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity DataRobert Jolly, Alejandra Trejo-Martin, Joel P Bercu, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2020
A cross-industry collaboration to assess if acute oral toxicity (Q)SAR models are fit-for-purpose for GHS classification and labellingJoel Bercu, Melisa J Masuda-Herrera, Alejandra Trejo-Martin, et al.
Mutagenesis|September 7, 2018
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?Alexander Amberg, Lennart T Anger, Joel Bercu, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2019
Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi<sup>®</sup> and Epclusa<sup>®</sup>John O Link, James G Taylor, Alejandra Trejo-Martin, et al.
Regulatory Toxicology and Pharmacology : RTP|May 1, 2025
HESI GTTC ring trial: Concordance between Ames and rodent carcinogenicity outcomes for N-nitrosamines (NAs) with rat and hamster metabolic conditionsJoel Bercu, Alejandra Trejo-Martin, Connie Chen, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2018
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Roxanne V Andaya, Lennart T Anger, et al.
Computational Toxicology (Amsterdam, Netherlands)|April 4, 2022
<i>In Silico</i> Approaches In Carcinogenicity Hazard Assessment: Current Status and Future NeedsRaymond R Tice, Arianna Bassan, Alexander Amberg, et al.
Regulatory Toxicology and Pharmacology : RTP|June 14, 2019
Genetic toxicology in silico protocolCatrin Hasselgren, Ernst Ahlberg, Yumi Akahori, et al.
Regulatory Toxicology and Pharmacology : RTP|April 22, 2018
In silico toxicology protocolsGlenn J Myatt, Ernst Ahlberg, Yumi Akahori, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Regulatory Toxicology and Pharmacology : RTP|February 1, 2026
Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity DataRobert Jolly, Alejandra Trejo-Martin, Joel P Bercu, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2020
A cross-industry collaboration to assess if acute oral toxicity (Q)SAR models are fit-for-purpose for GHS classification and labellingJoel Bercu, Melisa J Masuda-Herrera, Alejandra Trejo-Martin, et al.
Mutagenesis|September 7, 2018
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?Alexander Amberg, Lennart T Anger, Joel Bercu, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2019
Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi<sup>®</sup> and Epclusa<sup>®</sup>John O Link, James G Taylor, Alejandra Trejo-Martin, et al.
Regulatory Toxicology and Pharmacology : RTP|May 1, 2025
HESI GTTC ring trial: Concordance between Ames and rodent carcinogenicity outcomes for N-nitrosamines (NAs) with rat and hamster metabolic conditionsJoel Bercu, Alejandra Trejo-Martin, Connie Chen, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2018
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Roxanne V Andaya, Lennart T Anger, et al.
Computational Toxicology (Amsterdam, Netherlands)|April 4, 2022
<i>In Silico</i> Approaches In Carcinogenicity Hazard Assessment: Current Status and Future NeedsRaymond R Tice, Arianna Bassan, Alexander Amberg, et al.
Regulatory Toxicology and Pharmacology : RTP|June 14, 2019
Genetic toxicology in silico protocolCatrin Hasselgren, Ernst Ahlberg, Yumi Akahori, et al.
Regulatory Toxicology and Pharmacology : RTP|April 22, 2018
In silico toxicology protocolsGlenn J Myatt, Ernst Ahlberg, Yumi Akahori, et al.
Pageof 2